-
Lymph Node Dissection in Lung Cancer: A Paradigm in Flux
Dr. Witold Rzyman explores the ongoing debate over lymph node dissection in early-stage lung cancers, suggesting that a shift toward a tailored lymphadenectomy may be strongly justified.
More News from ILCN
-
Computed Tomography Via a Mobile Unit Brings Care Pathway Closer to High-Risk Underserved Populations, Expands Access to Lung Cancer Screening
In the BRELT3 study, Dr. Ricardo Sales dos Santos said LDCT-based screening delivered using a mobile unit—along with community health worker-based recruitment—enabled high-risk and underserved groups in a resource-limited setting in Brazil to access lung cancer screening.
-
cSRT May Improve Survival Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer Treated With Osimertinib, Especially as a Consolidative Approach
A retrospective study conducted in China suggests improved outcomes with incorporation of early cranial stereotactic radiotherapy for patients with EGFR-mutant NSCLC and limited-volume brain metastases who were receiving frontline osimertinib treatment, as reported by Dr. Zhengfei Zhu.